Format
Items per page
Sort by

Send to:

Choose Destination

Links from PubMed

Items: 12

1.

The association of retinoic acid receptor beta2(RARβ2) methylation status and prostate cancer risk: a systematic review and meta-analysis.

Gao T, He B, Pan Y, Li R, Xu Y, Chen L, Nie Z, Gu L, Wang S.

PLoS One. 2013 May 13;8(5):e62950. doi: 10.1371/journal.pone.0062950. Print 2013. Review.

2.

Association between RASSF1A promoter methylation and prostate cancer: a systematic review and meta-analysis.

Pan J, Chen J, Zhang B, Chen X, Huang B, Zhuang J, Mo C, Qiu S.

PLoS One. 2013 Sep 20;8(9):e75283. doi: 10.1371/journal.pone.0075283. eCollection 2013. Review.

3.

The association of RAS association domain family Protein1A (RASSF1A) methylation states and bladder cancer risk: a systematic review and meta-analysis.

Gao T, Wang S, He B, Pan Y, Song G, Gu L, Chen L, Nie Z, Xu Y, Li R.

PLoS One. 2012;7(11):e48300. doi: 10.1371/journal.pone.0048300. Epub 2012 Nov 6. Review.

4.

The emerging roles of DNA methylation in the clinical management of prostate cancer.

Perry AS, Foley R, Woodson K, Lawler M.

Endocr Relat Cancer. 2006 Jun;13(2):357-77. Review.

5.

Urinary biomarkers for prostate cancer: a review.

Hessels D, Schalken JA.

Asian J Androl. 2013 May;15(3):333-9. doi: 10.1038/aja.2013.6. Epub 2013 Mar 25. Review.

6.

DNA methylation changes in prostate cancer: current developments and future clinical implementation.

Hoque MO.

Expert Rev Mol Diagn. 2009 Apr;9(3):243-57. doi: 10.1586/erm.09.10. Review.

7.

The role of prostatitis in prostate cancer: meta-analysis.

Jiang J, Li J, Yunxia Z, Zhu H, Liu J, Pumill C.

PLoS One. 2013 Dec 31;8(12):e85179. doi: 10.1371/journal.pone.0085179. eCollection 2013. Review.

8.

APC gene hypermethylation and prostate cancer: a systematic review and meta-analysis.

Chen Y, Li J, Yu X, Li S, Zhang X, Mo Z, Hu Y.

Eur J Hum Genet. 2013 Sep;21(9):929-35. doi: 10.1038/ejhg.2012.281. Epub 2013 Jan 9. Review.

9.

Methylation markers for prostate cancer prognosis: a systematic review.

Chao C, Chi M, Preciado M, Black MH.

Cancer Causes Control. 2013 Sep;24(9):1615-41. Review.

PMID:
23797237
10.

Epigenetic markers for molecular detection of prostate cancer.

Costa VL, Henrique R, Jerónimo C.

Dis Markers. 2007;23(1-2):31-41. Review.

11.
12.

DNA methylation biomarkers of cancer: moving toward clinical application.

Levenson VV.

Pharmacogenomics. 2004 Sep;5(6):699-707. Review.

PMID:
15335290
Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk